skip to main content
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE
Material Type:
Artigo
Adicionar ao Meu Espaço

Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE

Gaspar, N. ; Marshall, L.V. ; Binner, D. ; Herold, R. ; Rousseau, R. ; Blanc, P. ; Capdeville, R. ; Carleer, J. ; Copland, C. ; Kerloeguen, Y. ; Norga, K. ; Pacaud, L. ; Sevaux, M.-A. ; Spadoni, C. ; Sterba, J. ; Ligas, F. ; Taube, T. ; Uttenreuther-Fischer, M. ; Chioato, S. ; O'Connell, M.A. ; Geoerger, B. ; Blay, J.-Y. ; Soria, J.C. ; Kaye, S. ; Wulff, B. ; Brugières, L. ; Vassal, G. ; Pearson, A.D.J.

Annals of oncology, 2018-03, Vol.29 (3), p.766-771 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

2
Inclusion of adolescents in adult early phase trials and young adults in paediatric early phase trials: A reality or a myth?
Material Type:
Artigo
Adicionar ao Meu Espaço

Inclusion of adolescents in adult early phase trials and young adults in paediatric early phase trials: A reality or a myth?

Vozy, A. ; Berlanga Charriel, P. ; Geoerger, B. ; Massard, C. ; Gaspar, N.

Annals of oncology, 2018-10, Vol.29, p.viii713-viii713 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

3
Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach
Material Type:
Artigo
Adicionar ao Meu Espaço

Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach

Tan, D.S.W. ; Lassen, U.N. ; Albert, C.M. ; Kummar, S. ; van Tilburg, C. ; Dubois, S.G. ; Geoerger, B. ; Mascarenhas, L. ; Federman, N. ; Basu-Mallick, A. ; Doz, F. ; Berlin, J.D. ; Oh, D.-Y. ; Bielack, S. ; McDermott, R. ; Cruickshank, S. ; Ku, N.C. ; Cox, M.C. ; Drilon, A. ; Hong, D.S.

Annals of oncology, 2018-11, Vol.29, p.ix23-ix23 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

4
Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach
Material Type:
Artigo
Adicionar ao Meu Espaço

Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach

Lassen, U N ; Albert, C M ; Kummar, S ; van Tilburg, C M ; Dubois, S G ; Geoerger, B ; Mascarenhas, L ; Federman, N ; Schilder, R J ; Doz, F ; Berlin, J D ; Oh, D-Y ; Bielack, S S ; McDermott, R ; Tan, D S ; Cruickshank, S ; Ku, N C ; Cox, M C ; Drilon, A ; Hong, D S

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii133 [Periódico revisado por pares]

England

Texto completo disponível

5
277 INVITED IGF1R Targeting in Non-sarcoma Pediatric Malignancies
Material Type:
Artigo
Adicionar ao Meu Espaço

277 INVITED IGF1R Targeting in Non-sarcoma Pediatric Malignancies

Geoerger, B

European journal of cancer (1990), 2011, Vol.47, p.S64-S65 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

6
Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSé program
Material Type:
Artigo
Adicionar ao Meu Espaço

Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSé program

Vassal, G ; Cozic, N ; Houot, R ; Brugières, L ; Aparicio, T ; Blay, J-Y ; Perol, M ; Brice, P ; Meriaux, E ; Geoerger, B ; El Bejjani, M R ; Moalla, S ; Bièche, I ; Lantuejoul, S ; Mahier Ait Oukhatar, C ; Hoog Labouret, N ; Moro-Sibilot, D

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii142 [Periódico revisado por pares]

England

Texto completo disponível

7
Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed population

Fischer, M ; Wulff, B ; Baruchel, S ; Berlanga, P ; Trahair, T ; Mechinaud, F ; Schulte, J ; Modak, S ; Merks, J.H ; Zwaan, C.M ; Marshall, L.V ; Casanova, M ; Branle, F ; Malet, I ; Emeremni, A.C ; Geoerger, B

European journal of cancer (1990), 2016-12, Vol.69, p.S49-S50 [Periódico revisado por pares]

Oxford: Elsevier Science Ltd

Texto completo disponível

8
347 Efficacy of Dasatinib in Targeting Diffuse Intrinsic Pontine Glioma (DIPG) Specific Pathway Activation in Vitro
Material Type:
Artigo
Adicionar ao Meu Espaço

347 Efficacy of Dasatinib in Targeting Diffuse Intrinsic Pontine Glioma (DIPG) Specific Pathway Activation in Vitro

Truffaux, N ; Puget, S ; Vassal, G ; Geoerger, B ; Grill, J

European journal of cancer (1990), 2012-11, Vol.48, p.106-106 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

9
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials
Material Type:
Artigo
Adicionar ao Meu Espaço

A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials

Doussau, A. ; Thiébaut, R. ; Geoerger, B. ; Schöffski, P. ; Floquet, A. ; Le Deley, M.C. ; Mathoulin-Pélissier, S. ; Rizzo, E. ; Fumoleau, P. ; Le Tourneau, C. ; Paoletti, X.

Annals of oncology, 2015-02, Vol.26 (2), p.422-428 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

10
Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts
Material Type:
Artigo
Adicionar ao Meu Espaço

Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts

Geoerger, B ; Grill, J ; Opolon, P ; Morizet, J ; Aubert, G ; Lecluse, Y ; van Beusechem, V W ; Gerritsen, W R ; Kirn, D H ; Vassal, G

British journal of cancer, 2003-08, Vol.89 (3), p.577-584 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (152)
  2. Revistas revisadas por pares (116)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (133)
  2. Book Chapters  (38)
  3. Livros  (30)
  4. Anais de Congresso  (14)
  5. Audio  (5)
  6. Reports  (2)
  7. Videos  (1)
  8. Recursos Textuais  (1)
  9. Dissertações  (1)
  10. Outros  (1)
  11. Mais opções open sub menu

Data de Publicação 

De até
  1. Antes de1979  (12)
  2. 1979Até1994  (15)
  3. 1995Até2005  (26)
  4. 2006Até2014  (76)
  5. Após 2014  (86)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (157)
  2. Alemão  (65)
  3. Japonês  (9)
  4. Francês  (7)
  5. Norueguês  (6)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.